VivoSeq
Other

Hemorrhage

111

Pipeline Programs↗

16

Active Trials↗

46

Companies Involved↗

Hemorrhage is a highly competitive landscape with 111 programs across 46 companies. The most active players are Ahon Pharmaceutical Co., Ltd., Neurim Pharmaceuticals Ltd., Sun Pharma. 33 therapies are approved with 31 more in late-stage development.

Intelligence

Pipeline Metrics

Competitive Density

72/100

Pipeline Velocity

25/100

Mech. Concentration

8/100

Completion Rate

80/100

Attrition Rate

12/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

A

Ahon Pharmaceutical Co., Ltd.

2 programs

Phase 1N

Neurim Pharmaceuticals Ltd.

1 program

Phase 1Sun Pharma logo

Sun Pharma

1 program

Phase 1A

Asia Cell Therapeutics (Shanghai) Co., Ltd.

1 program

Phase 1Orion Corporation, Orion Pharma logo

Orion Corporation, Orion Pharma

1 program

Phase 2L

Livzon Pharmaceutical Group Inc.

1 program

Phase 2

Pipeline

Programs by Phase

Analysis

Modality Breakdown

94%

Small molecule

120 of 127 classified programs — the dominant modality here.

6%ALL OTHERSMonoclonal antibody43%Protein / enzyme22%Cell therapy1<1%

Small molecule leads; the ring shows all 127 classified programs, each share of the total. Modality classified for 100% of 138 pipeline programs.

Analysis

Trial Status

95

clinical trials

Completed44 · 46%
Unknown status24 · 25%
Recruiting9 · 9%
Terminated8 · 8%
Not yet recruiting6 · 6%
Withdrawn3 · 3%
Other1 · 1%

Clinical Trials

Trial Activity

95 trials

A Randomized Controlled Trial of Inhaled Tranexamic Acid for the Treatment of Pulmonary Hemorrhage in Cancer Patients
Recruiting·MM.D. Anderson Cancer Center·Phase 3·NCT05053867·60 enrolled
A Trial for Minimally Invasive Neurosurgery With AI-assisted Robotic Guidance for Moderate Basal Ganglia Hemorrhage (RAINBOW-MBH)
Recruiting·SSecond Affiliated Hospital, School of Medicine, Zhejiang University·N/A·NCT06465719·330 enrolled
Changes in Hemorrhage With Prophylactic Oxytocin for Dilation and Evacuation
Recruiting·UUniversity of Colorado, Denver·Phase 2·NCT06141447·150 enrolled
rhTNK-tPA Thrombolytic Removal of Intraventricular Hemorrhage
Recruiting·—·Phase 1·NCT06814964·18 enrolled
Application of tPA in Suprachoroidal and Subretinal Hemorrhage
Recruiting·SSecond Affiliated Hospital, School of Medicine, Zhejiang University·N/A·NCT05736757·20 enrolled
Tocilizumab-aazg for Hemorrhage: Reduction of Ischemic Vascular Events
Recruiting·UUniversity of Florida·Phase 1·NCT06863480·30 enrolled
Statins In Intracerbral Hemorrhage
Recruiting·—·Phase 3·NCT03936361·1,456 enrolled
An Open Label, Prospective, Randomized, Parallel Groups, Multicenter Study to Compare the Efficacy and Safety of TachoSil® Versus Surgicel™ Original (Oxidized Regenerated Cellulose) as an Adjunct to Control Mild to Moderate Soft Tissue Bleeding During Surgery.
Recruiting·CCorza Medical GmbH·Phase 3·NCT06664775·116 enrolled
Safety of Combined Therapy With Erythropoietin and Melatonin for Very Preterm Infants With Intraventricular Hemorrhage (SCEMPI)
Recruiting·JJohns Hopkins University·Phase 1·NCT05617833·60 enrolled
The HeLiX (Hemorrhage During Liver Resection: traneXamic Acid) Trial
Active, not recruiting·SSunnybrook Health Sciences Centre·Phase 3·NCT02261415·1,386 enrolled
Sublingual Oxytocin for the Prevention of Post-partum Hemorrhage
Not yet recruiting·IInsud Pharma·Phase 2·NCT06968481·330 enrolled
Calcium Administration in Life-saving Management During Massive Hemorrhage
Not yet recruiting·LLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's·Phase 2/3·NCT06820645·81 enrolled
TranExamic Atomized for Pediatric Post-Operative Tonsillectomy Hemorrhage: Pilot Study
Not yet recruiting·TThe University of Texas Health Science Center at San Antonio·Phase 1·NCT06580509·12 enrolled
Comparative Effectiveness of INTERCEPT Fibrinogen Complex (IFC) and Cryoprecipitate-AHF (Cryo-AHF) for Treatment of Trauma Associated Hemorrhage
Not yet recruiting·CCerus Corporation·N/A·NCT07218185·320 enrolled
ROLE OF PROPHYLACTIC TRANEXAMIC ACID IN PREVENTION OF POST-PARTUM HEMORRHAGE IN ELLSCS
Not yet recruiting·PPatel Hospital, Pakistan·Phase 1·NCT07002749·104 enrolled
Page 1 of 7

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)